Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pediatric Relapsed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05252403
What this trial is testing

Residual Disease Driven Strategy for CARCIK (CD19) in Adults/Pediatric BCP-ALL

Who this might be right for
Acute Lymphoblastic Leukemia
Fondazione Matilde Tettamanti Menotti De Marchi Onlus 35
Not applicableLooking for participantsNCT05512169
What this trial is testing

Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia

Who this might be right for
ALL, ChildhoodPediatric CancerToxicity, Drug+5 more
University of Geneva, Switzerland 556
Testing effectiveness (Phase 2)Looking for participantsNCT06508931
What this trial is testing

Safety and Efficacy Study of Zamtocabtagene Autoleucel (MB-CART2019.1) in Pediatric Patients With R/R B-Cell Neoplasms

Who this might be right for
B-Cell Neoplasm
Miltenyi Biomedicine GmbH 31
Early research (Phase 1)UnknownNCT05727683
What this trial is testing

CD19-targeted CAR T Cells for Patients With Relapsed or Refractory in B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphocytic Leukemia
Shanghai Ming Ju Biotechnology Co., Ltd. 33
Early research (Phase 1)WithdrawnNCT02680951
What this trial is testing

Dasatinib in Combination With Chemotherapy for Relapsed or Refractory Core Binding Factor Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Emory University
Early research (Phase 1)Study completedNCT04996160
What this trial is testing

Palbociclib in Combo w/Chemotherapy in Peds Relapsed/Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia, PediatricRelapsed Acute Lymphoblastic LeukemiaRefractory Acute Lymphoblastic Leukemia
Tanja Andrea Gruber 2
Early research (Phase 1)Ended earlyNCT01655875
What this trial is testing

AMD3100 for Sensitizing in Allogeneic Blood or Marrow Transplant for Chemotherapy Resistant Pediatric Acute Leukemia

Who this might be right for
Pediatric Acute Myeloblastic Leukemia, RelapsedPediatric Acute Lymphoblastic Leukemia, Relapsed
Emory University 1
Testing effectiveness (Phase 2)Study completedNCT02410200
What this trial is testing

Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 22
Early research (Phase 1)Looking for participantsNCT06612645
What this trial is testing

Safety and Efficacy of CMD03 CAR T Cell in Children With Relapse or Refractory Solid Tumors

Who this might be right for
Pediatric CancersSolid Tumor Pediatric
Chulalongkorn University 9
Testing effectiveness (Phase 2)UnknownNCT03628131
What this trial is testing

Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors

Who this might be right for
Relapsed Pediatric Solid TumorRefractory Pediatric Solid Tumor
Samsung Medical Center 46
Large-scale testing (Phase 3)Active Not RecruitingNCT03958877
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 152
Early research (Phase 1)Looking for participantsNCT07306832
What this trial is testing

Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
AbbVie 18
Not applicableLooking for participantsNCT06866873
What this trial is testing

CD-19 CAR-T Cell for Pediatric ALL or Lymphoma

Who this might be right for
Lymphoma, B-CellAcute Lymphoblastic Leukemia, Pediatric
Hong Kong Children's Hospital 18
Testing effectiveness (Phase 2)Study completedNCT02499861
What this trial is testing

Phase I/II a Study of Decitabine in Combination With Genistein in Pediatric Relapsed or Refractory Malignancies

Who this might be right for
Cancer
St. Justine's Hospital 6
Testing effectiveness (Phase 2)Study completedNCT01780662
What this trial is testing

Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Recurrent Adult Hodgkin LymphomaRecurrent Childhood Hodgkin LymphomaRefractory Childhood Hodgkin Lymphoma
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Ended earlyNCT03705507
What this trial is testing

International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic Leukaemia

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia, AdultAcute Lymphoblastic Leukemia, Pediatric+2 more
University of Birmingham 12
Early research (Phase 1)Study completedNCT03263936
What this trial is testing

Epigenetic Reprogramming in Relapse/Refractory AML

Who this might be right for
Acute Myelogenous Leukemia
Therapeutic Advances in Childhood Leukemia Consortium 37
Early research (Phase 1)Active Not RecruitingNCT01683279
What this trial is testing

A Pediatric Trial of Genetically Modified Autologous T Cells Directed Against CD19 for Relapsed CD19+ Acute Lymphoblastic Leukemia

Who this might be right for
B Cell Leukemia
Seattle Children's Hospital 6
Testing effectiveness (Phase 2)Study completedNCT00002704
What this trial is testing

Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
National Cancer Institute (NCI) 156
Early research (Phase 1)Looking for participantsNCT07156435
What this trial is testing

Vyxeos® With Clofarabine for Pediatric AML

Who this might be right for
Relapsed Pediatric AMLRefractory Pediatric AML
Princess Maxima Center for Pediatric Oncology 25
Next Page